David Moadel

David Moadel

InvestorPlace Contributor

Expertise: Stocks, Options, Precious metals, Bitcoin, Altcoins

Education: Master's degree in education from the American College of Education, Bachelor's degree in education from Florida Atlantic University, Associate's degree in liberal arts from Palm Beach Community College

About David:
David Moadel is a financial writer for InvestorPlace.com. He has a master’s degree in education and has authored financial content for multiple websites.

David is also active as a social media influencer, with tens of thousands of followers on YouTube, Twitter, StockTwits, and other popular sites. David writes on topics ranging from stocks to cryptocurrencies, options, precious metals, bonds, futures, and other areas of finance.

Focusing on data rather than emotions, David is always on the lookout for new pathways to financial freedom. Count on David for wealth-building strategies and resources for investors and traders of all financial backgrounds.

You can follow David on YouTube, Twitter, StockTwits and LinkedIn.

Recent Articles

Buy Workhorse on Biden’s Promise of Fleet Electrification

By David Moadel, InvestorPlace Contributor

A presidential decree for carbon-neutral federal fleets and an $8.1 billion USPS contract up for grabs means good news for WKHS stock.

Bet on an Up-and-Coming Cannabis SaaS Player With Silver Spike Acquisition

By David Moadel, InvestorPlace Contributor

SSPK stock can get investors into the emerging marijuana market via software, so they don't even have to get involved with cannabis plants.

Capture a Vast Addressable EV Market with CIIG Merger Stock

By David Moadel, InvestorPlace Contributor

Not every electric vehicle stock has to focus on fancy cars. With CIIC stock, you can target an EV player with significant cost advantages.

Sundial Growers Stock Simply Isn’t Priced to Buy Right Now

By David Moadel, InvestorPlace Contributor

SNDL stock is beloved by risk-seeking retail traders, but Wall Street remains cautious as the short-squeeze hype quickly fades.

Ignore Short-Seller Attack and Stick with Clover Health

By David Moadel, InvestorPlace Contributor

Don't ignore the accusations posed by Hindenburg, but at the same time, there's no need to dump your shares of CLOV stock.

Load More